FindTrial
Sign In

Non-Hodgkins lymphoma T-cell protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73274643
Enrollment
Unknown
Registered
2001-07-01
Start date
1997-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma (non-Hodgkins) Cancer Lymphoma (non-Hodgkins)

Interventions

1. Group A: Chemotherapy including third intensification block at 35 weeks 2. Group B: Chemotherapy without third intensification block at 35 weeks

Sponsors

Cancer Research UK (CRUK) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. T-cell non-Hodgkin's lymphoma 2. Stages I-IV 3. Confirmed remission achieved 4. Less than 25% blasts in bone marrow 5. No circulating blasts in blood 6. Aged <18 years

Exclusion criteria

Exclusion criteria: Patients with T-cell anaplastic lymphoma or peripheral T-cell lymphoma are excluded.

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026